BACKGROUND: The mucosal lymphocyte population is the largest in the body, and the gastrointestinal compartment has been well characterized in HIV infection. Much less is known about the effects of HIV on the genital tract. OBJECTIVE: : To examine the T-lymphocyte phenotype and receptor repertoire as well as total and virus-specific immunoglobulin concentrations in the endocervix of HIV-infected women at different stages of infection as compared with uninfected women. PATIENTS AND METHODS: Participants were 12 seronegative women, 10 HIV-infected "slow progressors" not taking antiretroviral therapy, and 9 HIV-infected women whose antiretroviral therapy was failing. We used multiparameter flow cytometry to enumerate T-cell populations on cytobrush-obtained cervical specimens, the immunoscope technique to determine the T-cell receptor (TCR) repertoire, and quantitative enzyme-linked immunosorbent assays for antibody determinations on cervical secretions absorbed onto ophthalmic sponges. Nonparametric statistical analyses were performed. RESULTS: We found marked depletion of leukocytes and CD4 T lymphocytes in the endocervix of HIV-infected women as compared with uninfected women; this was significant at more advanced disease stages. Naive T cells were rare in the endocervix of all groups. Activation marker expression was higher in endocervical T lymphocytes than in peripheral blood among control and slow-progressing HIV-infected women but not in women failing therapy. Endocervical T lymphocytes showed highly restricted utilization of Vbeta TCR families. Unlike other mucosal sites, the cervix contained IgG as the predominant immunoglobulin isotype. HIV-IgG was detected in the cervix of most HIV-infected women and in blood of all infected women. CONCLUSIONS: HIV infection induces substantial changes in the immune profile of the female genital tract. Further study of the implications of these findings for HIV acquisition and transmission is needed.
BACKGROUND: The mucosal lymphocyte population is the largest in the body, and the gastrointestinal compartment has been well characterized in HIV infection. Much less is known about the effects of HIV on the genital tract. OBJECTIVE: : To examine the T-lymphocyte phenotype and receptor repertoire as well as total and virus-specific immunoglobulin concentrations in the endocervix of HIV-infectedwomen at different stages of infection as compared with uninfected women. PATIENTS AND METHODS: Participants were 12 seronegative women, 10 HIV-infected "slow progressors" not taking antiretroviral therapy, and 9 HIV-infectedwomen whose antiretroviral therapy was failing. We used multiparameter flow cytometry to enumerate T-cell populations on cytobrush-obtained cervical specimens, the immunoscope technique to determine the T-cell receptor (TCR) repertoire, and quantitative enzyme-linked immunosorbent assays for antibody determinations on cervical secretions absorbed onto ophthalmic sponges. Nonparametric statistical analyses were performed. RESULTS: We found marked depletion of leukocytes and CD4 T lymphocytes in the endocervix of HIV-infectedwomen as compared with uninfected women; this was significant at more advanced disease stages. Naive T cells were rare in the endocervix of all groups. Activation marker expression was higher in endocervical T lymphocytes than in peripheral blood among control and slow-progressing HIV-infectedwomen but not in women failing therapy. Endocervical T lymphocytes showed highly restricted utilization of Vbeta TCR families. Unlike other mucosal sites, the cervix contained IgG as the predominant immunoglobulin isotype. HIV-IgG was detected in the cervix of most HIV-infectedwomen and in blood of all infected women. CONCLUSIONS:HIV infection induces substantial changes in the immune profile of the female genital tract. Further study of the implications of these findings for HIV acquisition and transmission is needed.
Authors: Rikke Olesen; Michael D Swanson; Martina Kovarova; Tomonori Nochi; Morgan Chateau; Jenna B Honeycutt; Julie M Long; Paul W Denton; Michael G Hudgens; Amy Richardson; Martin Tolstrup; Lars Østergaard; Angela Wahl; J Victor Garcia Journal: J Clin Invest Date: 2016-02-08 Impact factor: 14.808
Authors: Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer Journal: AIDS Date: 2010-01-16 Impact factor: 4.177
Authors: Amie L Meditz; Kerrie L Moreau; Samantha MaWhinney; Wendolyn S Gozansky; Kelsey Melander; Wendy M Kohrt; Margaret E Wierman; Elizabeth Connick Journal: J Acquir Immune Defic Syndr Date: 2012-03-01 Impact factor: 3.731
Authors: Rebecca G Nowak; Patti E Gravitt; Charles S Morrison; Stephen J Gange; Cynthia Kwok; Amy E Oliver; Roslyn Howard; Barbara Van der Pol; Robert A Salata; Nancy S Padian; Tsungai Chipato; Marshall Munjoma; David D Celentano Journal: J Infect Dis Date: 2011-04-15 Impact factor: 5.226
Authors: Amie L Meditz; Claire Palmer; Julie Predhomme; Kristina Searls; Becky Kerr; Sharon Seifert; Patricia Caraway; Edward M Gardner; Samantha MaWhinney; Peter L Anderson Journal: AIDS Res Hum Retroviruses Date: 2015-06-10 Impact factor: 2.205
Authors: Tara Henning; Yetunde Fakile; Christi Phillips; Elizabeth Sweeney; James Mitchell; Dorothy Patton; Gail Sturdevant; Harlan D Caldwell; W Evan Secor; John Papp; R Michael Hendry; Janet McNicholl; Ellen Kersh Journal: J Med Primatol Date: 2011-08 Impact factor: 0.667
Authors: Kristine E Johnson; Mark E Sherman; Victor Ssempiija; Aaron A R Tobian; Jonathan M Zenilman; Maire A Duggan; Godfrey Kigozi; David Serwadda; Maria J Wawer; Thomas C Quinn; Charles S Rabkin; Ronald H Gray Journal: AIDS Date: 2009-09-10 Impact factor: 4.177
Authors: Nonhlanhla N Nkwanyana; Pamela P Gumbi; Lindi Roberts; Lynette Denny; Willem Hanekom; Andreia Soares; Bruce Allan; Anna-Lise Williamson; David Coetzee; Abraham J Olivier; Wendy A Burgers; Jo-Ann Passmore Journal: Immunology Date: 2009-03-26 Impact factor: 7.397
Authors: Jessica L Prodger; Taha Hirbod; Ronald Gray; Godfrey Kigozi; Fred Nalugoda; Ronald Galiwango; Steven J Reynolds; Sanja Huibner; Maria J Wawer; David Serwadda; Rupert Kaul Journal: J Infect Dis Date: 2013-11-25 Impact factor: 5.226